How many KOL / HCP visits per week are you required to see? I work for a mid-sized company and we are required to see 9 people / week. I'm just curious to see if people think that is a lot / just right / or too little.
Depends on your territory when it comes to KOLs...HCP's are usually driven by requests. Work for a large Pharma Company and regarding KOLs, its about 3 a week (contacts). HCPs vary depending on requests/activity etc
We have an average "goal" not a hard number. It's based per quarter. Any company that has a weekly metric is really out of touch and mostly getting BS entries.
What is your average per quarter? Are the HCP/KOLs from a specific targeted list or are these any health care practitioners? Do you have any outcome metrics as well or strictly driven by number of calls/presentations?
An appropriate ratio depends very much on the type of KOL you are interacting with. A consultancy firm who is providing intelligence and metrics to organize your KOL Management is www.heartbeatexperts.com
Is your company big pharma, medium or small? In addition to this metric, do you have outcomes goals or reports as well? (e.g. discussion with Pharmacy director resulting in formulary acceptance)
OIG guidance is very clear: MSLs cannot be held responsible in any way for sales goals--including formulary acceptance. Metrics can include contacts, frequency, quality, etc., but they CAN NOT include any metrics related to sales data.
Formulary acceptance is not a sales metric. Please provide a link to OIG where they specifically call out MSLs and differentiate this function from any other function in a pharmaceutical company. thanks.
Agree with above poster. If formulary acceptance was just a sales metric, then what is the purpose of the Managed markets or institutional MSL? Getting a drug on formulary doesn't guarantee use or sales of that drug, just makes it accessible to prescribe.
WRONG. It is a sales metric per FDA interpretation from DDMAC dated 07/09. Similarly, OIG considers formulary decisions to be a commercial function based on administrative law decisions dating from 09/10 and 01/11. Check your facts before you post BS on this website.
Again, please provide links to substantiate your position. And I would ask your thoughts on the question that, if formulary acceptance was purely a commercial outcome, what is the outcome goal of the Managed markets MSL? ...and leave the attitude behind. There is plenty of opportunity to be an ass on the commercial boards
